Report: Spanish Association Against Cancer (Spain)

From Beacon

forpolicymakers spaincountry Go back to Spain page

Primary purpose: To address the current challenges and future prospects of palliative care and end-of-life support for the oncology population in Spain, focusing on multidisciplinary perspectives and biopsychosocial approaches.

Sponsor, manager or home institution: Asociación Española Contra el Cáncer.

Type of information: Estimation of the population with palliative needs; Evolution of the percentage of deaths of cancer patients; Number of palliative resources for adults; Social variables that hinder access to palliative care; Percentage of patients who receive radiotherapy; Percentage of patients who consume some pharmaceutical product directly derived from their treatment; Radiotherapy costs. Click here to learn more.

Data level: national level and regional level.

Cancer Areas of Interest: C00-C97: All cancer types. Click here to learn more.

Access to information: Click here to access; For radiotherapy information click here to access.

Mouth Throat Oropharynx Nasopharynx Hypopharynx Larynx Salivary glands Lips Tonsils base of tongue Voice box Esophagus Stomach Small intestine Large intestine Colon Rectum Anus Liver Gallbladder Bile ducts Pancreas Lung Trachea Bronchi Pleura Mediastinum Bone Cartilage Osteosarcoma Ewings sarcoma Skin Melanoma Scalp Lips Hands Feet Muscle Fat Tendon Ligament Blood vessels Connective tissue Sarcoma Angiosarcoma Liposarcoma Lobular Breast Nipple Areola Ductal Vulva Vagina Cervix Uterus Ovary Fallopian tubes Endometrium Prostate Testicles Penis Kidney Ureter Bladder Urethra Eye Brain Spinal cord Thyroid gland Parathyroid Adrenal glands Pituitary gland Pancreas Thymus gland Peritoneum Pericardium Retroperitoneum Mesothelium Blood Bone marrow Lymph nodes Spleen Leukemia dataOwner::Asociación Española Contra el Cáncer availableVariable::number of deaths|deaths availableVariable::palliative care availableVariable::medication use|pharmaceutical availableVariable::medical prodecures|treatment availableVariable::healthcare costs|Radiotherapy costs dataLevel::national level dataLevel::regional level isReport hasCancerType::C00-C97: All cancer types hasCancerType::C00-D48: All neoplasms hasCancerType::C00-C14: Mouth/throat cancers hasCancerType::C15-C26: Digestive system cancers hasCancerType::C30-C39: Lung/chest cancers hasCancerType::C40-C41: Bone cancers hasCancerType::C43-C44: Skin cancers/melanoma hasCancerType::C45-C49: Soft tissue cancer hasCancerType::C50: Breast cancer hasCancerType::C51-C58: Female genitalia cancers hasCancerType::C60-C63: Male genitalia cancer hasCancerType::C64-C68: Urinary system cancers hasCancerType::C69-C72: Eye and brain cancer hasCancerType::C73-C75: Thyroid and other gland cancers hasCancerType::C76-C80: Cancers of unknown or unspecified areas hasCancerType::C81-C96: Cancers of the blood and immune system hasCancerType::C97-C97: Cancers in multiple locations from the start Head Neck Oral Oral cavity Pharynx Pharyngeal Tongue Lingual Nasal cavity Nasal Sinonasal Sinus Sinuses Paranasal sinuses Ear Mandible Maxilla Jaw Esophageal Gastric Intestinal Bowel Colorectal Appendix Appendiceal Duodenum Jejunum Ileum Anal Perianal Hepatic Biliary Hepatobiliary Pulmonary Thorax Thoracic Chest Mediastinal Pleural Cutaneous Dermal Epidermal Subcutaneous Skeletal Osseous Chondral Extremity Axilla Axillary Mammary Cervical Uterine Endometrial Ovarian Tubal Fallopian Vaginal Vulvar Adnexal Renal Urothelial Ureteral Urethral Prostatic Testicular Penile Ocular Orbital Retinal Optic nerve Meninges Meningeal Cerebral Cerebellar Brainstem Lymphatic Lymphoid Lymphoma Hematologic Hematopoietic Myeloma Plasma cell Diaphragm Peripheral nerve Heart Cardiac Endocrine